<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Prospective differentiation between reversible cerebral vasoconstriction syndrome and central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002633'>vasculitis</z:hpo> can be challenging </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that high-resolution vessel wall MRI would demonstrate arterial wall enhancement in central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002633'>vasculitis</z:hpo> but not in reversible cerebral vasoconstriction syndrome </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We identified <z:hpo ids='HP_0000001'>all</z:hpo> patients with multifocal segmental narrowing of large intracranial arteries who had high-resolution vessel wall MRI and follow-up angiography at our institute over a 4-year period and performed a detailed chart review </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Three patients lacked arterial wall enhancement, and these <z:hpo ids='HP_0000001'>all</z:hpo> had reversal of arterial narrowing within 3 months </plain></SENT>
<SENT sid="4" pm="."><plain>Four patients demonstrated arterial wall enhancement, and these had persistent or progressive arterial narrowing at a median follow-up of 17 months (range, 6-36 months) with final diagnoses of central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (3) and cocaine vasculopathy (1) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: Preliminary results suggest that high-resolution contrast-enhanced vessel wall MRI may enable differentiation between reversible cerebral vasoconstriction syndrome and central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
</text></document>